Logo image of MCS

MARCUS CORPORATION (MCS) Stock Fundamental Analysis

NYSE:MCS - US5663301068 - Common Stock

15.15 USD
-0.02 (-0.13%)
Last: 8/21/2025, 8:25:39 PM
15.15 USD
0 (0%)
After Hours: 8/21/2025, 8:25:39 PM
Fundamental Rating

4

Overall MCS gets a fundamental rating of 4 out of 10. We evaluated MCS against 74 industry peers in the Entertainment industry. There are concerns on the financial health of MCS while its profitability can be described as average. MCS has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

MCS had positive earnings in the past year.
MCS had a positive operating cash flow in the past year.
In the past 5 years MCS reported 4 times negative net income.
Of the past 5 years MCS 4 years had a positive operating cash flow.
MCS Yearly Net Income VS EBIT VS OCF VS FCFMCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

MCS has a Return On Assets of 1.46%. This is in the better half of the industry: MCS outperforms 68.92% of its industry peers.
MCS has a better Return On Equity (3.30%) than 72.97% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.26%, MCS is in the better half of the industry, outperforming 67.57% of the companies in the same industry.
MCS had an Average Return On Invested Capital over the past 3 years of 1.74%. This is significantly below the industry average of 23.18%.
The 3 year average ROIC (1.74%) for MCS is below the current ROIC(2.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.46%
ROE 3.3%
ROIC 2.26%
ROA(3y)-0.16%
ROA(5y)-2.82%
ROE(3y)-0.39%
ROE(5y)-7.15%
ROIC(3y)1.74%
ROIC(5y)N/A
MCS Yearly ROA, ROE, ROICMCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

MCS has a Profit Margin of 1.91%. This is in the better half of the industry: MCS outperforms 70.27% of its industry peers.
MCS's Operating Margin of 3.66% is fine compared to the rest of the industry. MCS outperforms 68.92% of its industry peers.
MCS's Operating Margin has declined in the last couple of years.
MCS has a Gross Margin of 38.85%. This is comparable to the rest of the industry: MCS outperforms 44.59% of its industry peers.
MCS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.66%
PM (TTM) 1.91%
GM 38.85%
OM growth 3YN/A
OM growth 5Y-18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.54%
MCS Yearly Profit, Operating, Gross MarginsMCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MCS is destroying value.
Compared to 1 year ago, MCS has less shares outstanding
The number of shares outstanding for MCS has been increased compared to 5 years ago.
MCS has a better debt/assets ratio than last year.
MCS Yearly Shares OutstandingMCS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MCS Yearly Total Debt VS Total AssetsMCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.59, we must say that MCS is in the distress zone and has some risk of bankruptcy.
With a decent Altman-Z score value of 1.59, MCS is doing good in the industry, outperforming 60.81% of the companies in the same industry.
A Debt/Equity ratio of 0.40 indicates that MCS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.40, MCS is in line with its industry, outperforming 51.35% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 1.59
ROIC/WACC0.3
WACC7.4%
MCS Yearly LT Debt VS Equity VS FCFMCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

MCS has a Current Ratio of 0.39. This is a bad value and indicates that MCS is not financially healthy enough and could expect problems in meeting its short term obligations.
MCS has a Current ratio of 0.39. This is amonst the worse of the industry: MCS underperforms 81.08% of its industry peers.
A Quick Ratio of 0.39 indicates that MCS may have some problems paying its short term obligations.
MCS has a Quick ratio of 0.39. This is in the lower half of the industry: MCS underperforms 78.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.39
Quick Ratio 0.39
MCS Yearly Current Assets VS Current LiabilitesMCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 159.21% over the past year.
MCS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.27%.
The Revenue has been decreasing by -2.17% on average over the past years.
EPS 1Y (TTM)159.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%135.94%
Revenue 1Y (TTM)13.27%
Revenue growth 3Y17.09%
Revenue growth 5Y-2.17%
Sales Q2Q%17.05%

3.2 Future

MCS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 69.10% yearly.
Based on estimates for the next years, MCS will show a small growth in Revenue. The Revenue will grow by 4.26% on average per year.
EPS Next Y273.51%
EPS Next 2Y114.54%
EPS Next 3Y69.1%
EPS Next 5YN/A
Revenue Next Year6.44%
Revenue Next 2Y5.41%
Revenue Next 3Y4.26%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MCS Yearly Revenue VS EstimatesMCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
MCS Yearly EPS VS EstimatesMCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 33.67 indicates a quite expensive valuation of MCS.
Compared to the rest of the industry, the Price/Earnings ratio of MCS indicates a somewhat cheap valuation: MCS is cheaper than 77.03% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.76, MCS is valued a bit more expensive.
A Price/Forward Earnings ratio of 22.39 indicates a rather expensive valuation of MCS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MCS indicates a somewhat cheap valuation: MCS is cheaper than 75.68% of the companies listed in the same industry.
MCS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.91, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.67
Fwd PE 22.39
MCS Price Earnings VS Forward Price EarningsMCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MCS is valued cheaper than 87.84% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.58
MCS Per share dataMCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

MCS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MCS's earnings are expected to grow with 69.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.12
PEG (5Y)N/A
EPS Next 2Y114.54%
EPS Next 3Y69.1%

4

5. Dividend

5.1 Amount

MCS has a Yearly Dividend Yield of 2.12%. Purely for dividend investing, there may be better candidates out there.
MCS's Dividend Yield is rather good when compared to the industry average which is at 6.76. MCS pays more dividend than 90.54% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, MCS has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.12%

5.2 History

The dividend of MCS decreases each year by -13.79%.
MCS has paid a dividend for at least 10 years, which is a reliable track record.
MCS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-13.79%
Div Incr Years2
Div Non Decr Years2
MCS Yearly Dividends per shareMCS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

MCS pays out 58.72% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP58.72%
EPS Next 2Y114.54%
EPS Next 3Y69.1%
MCS Yearly Income VS Free CF VS DividendMCS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M
MCS Dividend Payout.MCS Dividend Payout, showing the Payout Ratio.MCS Dividend Payout.PayoutRetained Earnings

MARCUS CORPORATION

NYSE:MCS (8/21/2025, 8:25:39 PM)

After market: 15.15 0 (0%)

15.15

-0.02 (-0.13%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners79.4%
Inst Owner Change-0.5%
Ins Owners5.01%
Ins Owner Change-3.11%
Market Cap474.19M
Analysts84.44
Price Target25.5 (68.32%)
Short Float %2.87%
Short Ratio2.95
Dividend
Industry RankSector Rank
Dividend Yield 2.12%
Yearly Dividend0.28
Dividend Growth(5Y)-13.79%
DP58.72%
Div Incr Years2
Div Non Decr Years2
Ex-Date08-25 2025-08-25 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.53%
Min EPS beat(2)-10.24%
Max EPS beat(2)15.3%
EPS beat(4)2
Avg EPS beat(4)-2.7%
Min EPS beat(4)-73%
Max EPS beat(4)57.12%
EPS beat(8)3
Avg EPS beat(8)-322.91%
EPS beat(12)5
Avg EPS beat(12)-221.55%
EPS beat(16)8
Avg EPS beat(16)-136.28%
Revenue beat(2)2
Avg Revenue beat(2)3.53%
Min Revenue beat(2)1.76%
Max Revenue beat(2)5.29%
Revenue beat(4)4
Avg Revenue beat(4)4.38%
Min Revenue beat(4)1.76%
Max Revenue beat(4)8.6%
Revenue beat(8)7
Avg Revenue beat(8)3.4%
Revenue beat(12)11
Avg Revenue beat(12)3.65%
Revenue beat(16)15
Avg Revenue beat(16)6.74%
PT rev (1m)-0.99%
PT rev (3m)-2.6%
EPS NQ rev (1m)-21.47%
EPS NQ rev (3m)-23.08%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.94%
Revenue NQ rev (1m)-3.71%
Revenue NQ rev (3m)-7%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE 33.67
Fwd PE 22.39
P/S 0.61
P/FCF N/A
P/OCF 5.97
P/B 1.06
P/tB 1.27
EV/EBITDA 6.58
EPS(TTM)0.45
EY2.97%
EPS(NY)0.68
Fwd EY4.47%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)2.54
OCFY16.74%
SpS24.79
BVpS14.33
TBVpS11.93
PEG (NY)0.12
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.46%
ROE 3.3%
ROCE 3.3%
ROIC 2.26%
ROICexc 2.3%
ROICexgc 2.52%
OM 3.66%
PM (TTM) 1.91%
GM 38.85%
FCFM N/A
ROA(3y)-0.16%
ROA(5y)-2.82%
ROE(3y)-0.39%
ROE(5y)-7.15%
ROIC(3y)1.74%
ROIC(5y)N/A
ROICexc(3y)1.83%
ROICexc(5y)N/A
ROICexgc(3y)2.03%
ROICexgc(5y)N/A
ROCE(3y)2.54%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-14.17%
ROICexc growth 3YN/A
ROICexc growth 5Y-14.65%
OM growth 3YN/A
OM growth 5Y-18.51%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.54%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 1.81
Cap/Depr 118.61%
Cap/Sales 10.81%
Interest Coverage 3.38
Cash Conversion 80.12%
Profit Quality N/A
Current Ratio 0.39
Quick Ratio 0.39
Altman-Z 1.59
F-Score7
WACC7.4%
ROIC/WACC0.3
Cap/Depr(3y)76.34%
Cap/Depr(5y)56.25%
Cap/Sales(3y)7.17%
Cap/Sales(5y)6.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)159.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%135.94%
EPS Next Y273.51%
EPS Next 2Y114.54%
EPS Next 3Y69.1%
EPS Next 5YN/A
Revenue 1Y (TTM)13.27%
Revenue growth 3Y17.09%
Revenue growth 5Y-2.17%
Sales Q2Q%17.05%
Revenue Next Year6.44%
Revenue Next 2Y5.41%
Revenue Next 3Y4.26%
Revenue Next 5YN/A
EBIT growth 1Y209.42%
EBIT growth 3YN/A
EBIT growth 5Y-20.28%
EBIT Next Year315.84%
EBIT Next 3Y69.89%
EBIT Next 5YN/A
FCF growth 1Y-109.14%
FCF growth 3Y-5.39%
FCF growth 5Y-20.4%
OCF growth 1Y-6.95%
OCF growth 3Y30.94%
OCF growth 5Y-5.98%